Canbiola Presentation from Annual Shareholder Meeting is Publicly Available
02 juil. 2019 08h50 HE
|
Canbiola, Inc.
Provides Details on Growth Strategy HICKSVILLE, NY, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer, manufacturer...
Canbiola Announces First Quarter 2019 Results
28 mai 2019 09h00 HE
|
Canbiola, Inc.
Quarterly Revenue Increased 741% and Almost Matching Entire Year 2018; Revenue Maintained Gross Margin of 49% HICKSVILLE, NY, May 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis
06 mai 2019 11h12 HE
|
Canbiola, Inc.
Adds Pharmaceutical and Business Operations Expertise with Key Relationships to Provide Growth Opportunities for Canbiola HICKSVILLE, NY, May 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Canbiola, Inc. (OTCQB: CANB) Announces the Formation of a New Wholly Owned Subsidiary- DuraMed, Inc.
24 janv. 2019 10h34 HE
|
Canbiola, Inc.
HICKSVILLE, NY, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) announces the formation of a new wholly owned subsidiary- DuraMed, Inc. In an effort to expand...